Lords Chloro Alkali Limited has secured listing approval from both the National Stock Exchange (NSE) and BSE Limited for 35,00,000 equity shares allotted through warrant conversion on preferential basis. The company announced this development through a regulatory filing dated April 09, 2026.

Share Allotment Details

The equity shares were issued following the conversion of 35,00,000 warrants at a predetermined price structure. The shares carry distinctive numbers ranging from 25153862 to 28653861.

Regulatory Approvals

The company received formal listing approvals from both major stock exchanges on April 08, 2026. NSE granted approval through letter reference NSE/LIST/53708, while BSE issued its approval via letter reference LOD/PREF/MV/FIP/37/2026-27.

Both exchanges confirmed their in-principle approval for listing the equity shares issued pursuant to warrant conversion on preferential basis. The shares will be listed and admitted to trading upon receipt of confirmation from depositories NSDL and CDSL regarding credit to beneficiaries' accounts.

Compliance Requirements

As part of the listing process, Lords Chloro Alkali Limited must ensure compliance with several regulatory provisions:

• Adherence to Regulation 167 of SEBI (ICDR) Regulations
• Filing of shareholding pattern in XBRL mode under Regulation 31(1)(c) of SEBI LODR Regulations, 2015, if shareholding change exceeds two percent
• Submission of confirmation letters from NSDL/CDSL regarding share crediting and lock-in requirements

Trading Approval Process

The exchanges have outlined specific requirements for trading approval. BSE emphasized that trading approval will be granted only after the company submits listing approval from NSE, confirmation letters from depositories, and any applicable lock-in confirmations for pre-preferential holdings.

According to SEBI regulations, listed entities must apply for trading approval within seven working days from the date of listing approval grant. The regulatory framework includes provisions for fines in case of non-compliance with specified timelines.

Corporate Communication

The regulatory filing was signed by Pankaj Mishra, Company Secretary & Compliance Officer of Lords Chloro Alkali Limited. The communication was addressed to both BSE Limited and National Stock Exchange of India Limited as required under Regulation 30 of SEBI Listing Regulations.

Lords chloro alkali Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate was filed with both the Bombay Stock Exchange and National Stock Exchange of India on April 4, 2026.

Regulatory Compliance Filing

The compliance certificate was submitted by Company Secretary Pankaj Mishra to fulfill the mandatory quarterly reporting requirements under SEBI regulations. The filing confirms the company's adherence to dematerialization procedures for physical share certificates during the fourth quarter of fiscal year 2026.

Registrar Confirmation

Alankit Assignments Limited, serving as the company's Registrar and Share Transfer Agent, provided the confirmation certificate required under the SEBI regulations. The registrar certified that all securities comprised in the physical certificates have been properly listed on stock exchanges and that due verification procedures were completed.

General Manager Kamal Garg from Alankit Assignments Limited confirmed that physical share certificates received for dematerialization were properly mutilated and cancelled, with the depository name substituted in records as the registered owner. This process ensures compliance with electronic trading requirements and maintains accurate shareholder records.

Stock Exchange Submissions

The compliance documents were simultaneously submitted to both major Indian stock exchanges where Lords Chloro Alkali Limited shares are traded. The company maintains its listing presence through these regulatory filings, ensuring continued compliance with exchange requirements and investor protection measures.

This quarterly filing represents part of the company's ongoing regulatory compliance obligations, ensuring transparency in share transfer and dematerialization processes for the benefit of shareholders and market participants.